US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Vitrafy Life Sciences Ltd (VFY) 銘柄情報

Vitrafy Life Sciences Ltd (VFY)

3.80

0.00

( 0.00% )

更新日時： 07:36:31

Vitrafy Life Sciences Ltd (VFY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

3.80

( - )

買値

3.80

売値

3.75

出来高

0.00

0.00 日の範囲 0.00

1.16 52 週間の範囲 3.43

時価総額

前日終値

3.80

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 38,502

発行済株式数

63,849,674

配当利回り

PER

-14.63

1 株当たり利益 (EPS)

-0.22

歳入

2.34M

純利益

-14.15M

Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, tr... Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.vitrafy.com

本社

Melbourne, Australia

設立

2026

Vitrafy Life Sciences Ltd is listed in the sector of the オーストラリア証券取引所 with ticker VFY. The last closing price for Vitrafy Life Sciences was AUD3.80. Over the last year, Vitrafy Life Sciences shares have traded in a share price range of AUD 1.16 to AUD 3.43.

Vitrafy Life Sciences currently has 63,849,674 shares in issue. The market capitalisation of Vitrafy Life Sciences is AUD242.63 million. Vitrafy Life Sciences has a price to earnings ratio (PE ratio) of -14.63.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.1	40.7407407407	2.7	3.43	2.67	45200	3.0107427	DE
4	1.3	52	2.5	3.43	2.33	32462	2.71347403	DE
12	2.055	117.76504298	1.745	3.43	1.555	40696	2.2997216	DE
26	2.36	163.888888889	1.44	3.43	1.28	36112	2.02465292	DE
52	2.3	153.333333333	1.5	3.43	1.16	29928	1.77156833	DE
156	1.8	90	2	3.43	1.08	37408	1.75787793	DE
260	1.8	90	2	3.43	1.08	37408	1.75787793	DE

VFY - Frequently Asked Questions (FAQ)

What is the current Vitrafy Life Sciences Ltd share price?

The current share price of Vitrafy Life Sciences Ltd is AUD 3.80

How many Vitrafy Life Sciences Ltd shares are in issue?

Vitrafy Life Sciences Ltd has 63,849,674 shares in issue

What is the market cap of Vitrafy Life Sciences Ltd?

The market capitalisation of Vitrafy Life Sciences Ltd is AUD 242.63M

What is the 1 year trading range for Vitrafy Life Sciences Ltd share price?

Vitrafy Life Sciences Ltd has traded in the range of AUD 1.16 to AUD 3.43 during the past year

What is the PE ratio of Vitrafy Life Sciences Ltd?

The price to earnings ratio of Vitrafy Life Sciences Ltd is -14.63

What is the cash to sales ratio of Vitrafy Life Sciences Ltd?

The cash to sales ratio of Vitrafy Life Sciences Ltd is 88.56

What is the registered address of Vitrafy Life Sciences Ltd?

The registered address for Vitrafy Life Sciences Ltd is 385 Bourke Street, Melbourne, Victoria, 3000

What is the Vitrafy Life Sciences Ltd website address?

The website address for Vitrafy Life Sciences Ltd is www.vitrafy.com

Viking61

Viking61 4分前

It’s been violated since the Net Worth Sweep.

ace65

Less than a month ago we were in the trips..so we have had traction.
Looks like it basing here for next leg up.

nwtf

Only thing suppressing trades is the lack of investors. Wake up.

Checksinthemail

Checksinthemail 6分前

Hera gives the FHFA one mission as conservator, and that is preserved and conserve . Hera does not require justification from the president, housing policy or market fluctuation.. in my opinion Hera is already violated

jour_trader

jour_trader 11分前

Completely agree on the intrinsic. Waiting game simply gets old. Few weeks away from next cc.

rich2

someone posted "Rich" might chime in

I KNOW WHAT I OWN, A chance for a grand slam home run from a little stinky pinky mining stock about to explode

anxiously awaiting the next news release

Moe2001

Moe2001 18分前

Which chrome Microsoft chrome 🤣? Ahh you think your words are useful lmaoo . BCAP LETS MAKE HISTORY 📈💥💨

mrwrn2010

mrwrn2010 20分前

“You realize we’ve dropped like 20% on what equates to 0.0005% of total shares per trading sessions.”

Bingo. What I’ve also been thinking about today is this - we just got acceptance of the ANDA filing for Eliquis. The price jumped after the announcement on slightly more volume but ha

dewophile

dewophile 25分前

Gsk retained some R and D in oncology and notably retained what became belantamab. I wonder if GSK gets back into oncology if belantamab didn’t show such promise (yet to be realized commercially). I feel like they bought tesaro to get some critical mass in oncology bc having just one drug launch is

jennybuystheblock

jennybuystheblock 25分前

Customers Bank... so close but so far away.

jennybuystheblock

jennybuystheblock 26分前

Down to $6.51, the $7.00s are an illusion. Sellers will sell eventually, if you hit the ask the price goes up quickly. Lift the chill for fair pricing, but management doesn't like that since it affects the incentive plan.

Genz2

Elon posted on X that Korea is awesome! Tesla has a $19 billion contract with Samsung!!! With Apple continuously struggling with Siri and Ai, why doesn’t Tesla join forces with Samsung to make a Tesla/Samsung phone that is cheaper and better than the iPhone? And like Tesla, if the phones were made i

nowwhat2

nowwhat2 27分前

https://investorshub.advfn.com/uimage/uploads/2026/6/10/mqnnrelva_june_9_2y_pull_back.jpg

Steady_T

Steady_T 31分前

In that case quit giving advice that you won't follow yourself.

Power of Emouna

Power of Emouna 34分前

Where's the BIG NEWS?! LoL 😂

zerosnoop

zerosnoop 34分前

The scare campaign by the PAID BASHERS & NAKED SHORT SELLERS is failing. Smart & educated investors aren't believing the LIES & NONSENSE being told by the NAKED SHORT SELLERS.

Why do these PAID BASHERS & NAKED SHORT SELLERS want to hang around like a bad smell unless they have an agen

sloppyjones

sloppyjones 35分前

A thought came to me. Maybe we are only seeing the free side to the app? I wonder if the rest of capabilities have just been turned off for now until they release the subscription model?
Notice how there isn't even an option to pay for a plan. I have a feeling that will be here soon and

barnstormer

barnstormer 44分前

Lolo, if you'll actually do some checking, I believe you'll find the FDA real world data issue is just someone's opinion as is the claim the FDA currently requires a closed system. Don't believe me, look it up it yourself.

joe botts

joe botts 55分前

Lol!!! So call Wertheim let me know how that goes? Lmao

sloppyjones

sloppyjones 56分前

This sounds promising!
https://www.linkedin.com/posts/jean-marc-herbet-97b4237a_vumelive-vumehongkong-worldcup2026-share-7470300813957971968-1a26/?utm_source=share&utm_medium=member_android&rcm=ACoAAAm5fn0BNNCgxoNsCsVMeAJ5eEU9hqPLf74

1kgwxman

1kgwxman 57分前

Why are you asking an investor for something only AMFN can provide?
If AMFN is too risky, then don't buy.
Penny stocks are risky.
Or wait until autumn and you'll have your answers.
I'm using gambling funds, so I'm fine with that risk.

Geez man...

NoMoDo

NoMoDo 58分前

I firmly believe that RWAX has incredible potential to be a great company. Not there yet, but potential. I want to provide my opinions on the company, both positive and negative, but I have decided that I won't post on Ihub again until my posting restrictions have been removed. I don't expect tha

surfkast

surfkast 59分前

Legal charges for what? 🤣

Vitrafy Life Sciences

iNAV RBS Market Access L...

iSign Media Solutions

Sentinel Resources

Ulster Bk.frbds

Platform Res 32

iShares China Index ETF

Virgin Money UK

OMX Copenhagen Consumer ...

KickSoccer Coin

Anglo Am.4.875a

Healthpeak Properties

Defiance Israel Fixed In...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。